» Articles » PMID: 31491386

Single Amino Acid Change Underlies Distinct Roles of H2A.Z Subtypes in Human Syndrome

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2019 Sep 7
PMID 31491386
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The developmental disorder Floating-Harbor syndrome (FHS) is caused by heterozygous truncating mutations in SRCAP, a gene encoding a chromatin remodeler mediating incorporation of histone variant H2A.Z. Here, we demonstrate that FHS-associated mutations result in loss of SRCAP nuclear localization, alter neural crest gene programs in human in vitro models and Xenopus embryos, and cause craniofacial defects. These defects are mediated by one of two H2A.Z subtypes, H2A.Z.2, whose knockdown mimics and whose overexpression rescues the FHS phenotype. Selective rescue by H2A.Z.2 is conferred by one of the three amino acid differences between the H2A.Z subtypes, S38/T38. We further show that H2A.Z.1 and H2A.Z.2 genomic occupancy patterns are qualitatively similar, but quantitatively distinct, and H2A.Z.2 incorporation at AT-rich enhancers and expression of their associated genes are both sensitized to SRCAP truncations. Altogether, our results illuminate the mechanism underlying a human syndrome and uncover selective functions of H2A.Z subtypes during development.

Citing Articles

Recombinant human growth hormone treatment of Floating-Harbor syndrome: a case report and literature review.

He Q, Deng Y, Xu L, Xu Z, Ding Y, Wu M BMC Pediatr. 2025; 25(1):97.

PMID: 39905328 PMC: 11796099. DOI: 10.1186/s12887-025-05437-7.


Characterizing the regulatory effects of H2A.Z and SWR1-C on gene expression during hydroxyurea exposure in Saccharomyces cerevisiae.

Brewis H, Stirling P, Kobor M PLoS Genet. 2025; 21(1):e1011566.

PMID: 39836664 PMC: 11761084. DOI: 10.1371/journal.pgen.1011566.


The "Ins and Outs and What-Abouts" of H2A.Z: A tribute to C. David Allis.

Diegmuller F, Leers J, Hake S J Biol Chem. 2025; 301(2):108154.

PMID: 39761855 PMC: 11808731. DOI: 10.1016/j.jbc.2025.108154.


Epigenetic modulation via the C-terminal tail of H2A.Z.

Imre L, Nanasi Jr P, Benhamza I, Enyedi K, Mocsar G, Bosire R Nat Commun. 2024; 15(1):9171.

PMID: 39448645 PMC: 11502880. DOI: 10.1038/s41467-024-53514-9.


The Function of H2A Histone Variants and Their Roles in Diseases.

Yin X, Zeng D, Liao Y, Tang C, Li Y Biomolecules. 2024; 14(8).

PMID: 39199381 PMC: 11352661. DOI: 10.3390/biom14080993.


References
1.
Rada-Iglesias A, Bajpai R, Prescott S, Brugmann S, Swigut T, Wysocka J . Epigenomic annotation of enhancers predicts transcriptional regulators of human neural crest. Cell Stem Cell. 2012; 11(5):633-48. PMC: 3751405. DOI: 10.1016/j.stem.2012.07.006. View

2.
Bonisch C, Hake S . Histone H2A variants in nucleosomes and chromatin: more or less stable?. Nucleic Acids Res. 2012; 40(21):10719-41. PMC: 3510494. DOI: 10.1093/nar/gks865. View

3.
Pegoraro C, Monsoro-Burq A . Signaling and transcriptional regulation in neural crest specification and migration: lessons from xenopus embryos. Wiley Interdiscip Rev Dev Biol. 2013; 2(2):247-59. DOI: 10.1002/wdev.76. View

4.
Bajpai R, Chen D, Rada-Iglesias A, Zhang J, Xiong Y, Helms J . CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature. 2010; 463(7283):958-62. PMC: 2890258. DOI: 10.1038/nature08733. View

5.
Liang X, Shan S, Pan L, Zhao J, Ranjan A, Wang F . Structural basis of H2A.Z recognition by SRCAP chromatin-remodeling subunit YL1. Nat Struct Mol Biol. 2016; 23(4):317-23. DOI: 10.1038/nsmb.3190. View